Dr. Desiree E. Doncals
Claim this profileSumma Health System - Akron Campus
Studies Breast Cancer
Studies Lung Cancer
7 reported clinical trials
34 drugs studied
Area of expertise
1Breast Cancer
HER2 negative
HER2 positive
ER positive
2Lung Cancer
Stage IV
Stage III
PD-L1 negative
Affiliated Hospitals
Clinical Trials Desiree E. Doncals is currently running
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Radiation + Immunotherapy
for Non-Small Cell Lung Cancer
This phase II/III trial compares the addition of radiation therapy to the usual treatment (immunotherapy with or without chemotherapy) versus (vs.) usual treatment alone in treating patients with non-small cell lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic) whose tumor is also negative for a molecular marker called PD-L1. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill tumor cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The addition of radiation therapy to usual treatment may stop the cancer from growing and increase the life of patients with advanced non-small cell lung cancer who are PD-L1 negative.
Recruiting1 award Phase 2 & 3
More about Desiree E. Doncals
Clinical Trial Related9 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Desiree E. Doncals has experience with
- Degarelix
- Radiation Therapy
- Triptorelin
- Leuprolide
- Histrelin
- Buserelin
Breakdown of trials Desiree E. Doncals has run
Breast Cancer
Lung Cancer
Prostate Adenocarcinoma
Breast cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Desiree E. Doncals specialize in?
Desiree E. Doncals focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are HER2 positive.
Is Desiree E. Doncals currently recruiting for clinical trials?
Yes, Desiree E. Doncals is currently recruiting for 3 clinical trials in Akron Ohio. If you're interested in participating, you should apply.
Are there any treatments that Desiree E. Doncals has studied deeply?
Yes, Desiree E. Doncals has studied treatments such as Degarelix, Radiation Therapy, Triptorelin.
What is the best way to schedule an appointment with Desiree E. Doncals?
Apply for one of the trials that Desiree E. Doncals is conducting.
What is the office address of Desiree E. Doncals?
The office of Desiree E. Doncals is located at: Summa Health System - Akron Campus, Akron, Ohio 44304 United States. This is the address for their practice at the Summa Health System - Akron Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.